FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Moore

Research Profile

Disorders

Chemicals & Drugs

Physiology

Anatomy

Brain

Concepts & Ideas

Procedures

Living Beings

Devices

Oligonucleotide Array Sequence Analysis

Co-author Network

Publications

TOP 3
Nitish V Thakor; Robbin A Miranda; David F Moore; Geoffrey S F Ling
Special issue of DARPA NEST proceedings.
David F Moore; Roggin Miranda; Geoffrey S F Ling
DARPA Nest.
Jin-Song Shen; Xing-Li Meng; David F Moore; Jane M Quirk; James A Shayman; Raphael Schiffmann; Christine R Kaneski
Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Moore (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Nitish V Thakor; Robbin A Miranda; David F Moore; Geoffrey S F Ling
Special issue of DARPA NEST proceedings.
IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society 2012;20(2):113-6.
2012: David F Moore; Roggin Miranda; Geoffrey S F Ling
DARPA Nest.
IEEE pulse 2012;3(1):14.
2008: Jin-Song Shen; Xing-Li Meng; David F Moore; Jane M Quirk; James A Shayman; Raphael Schiffmann; Christine R Kaneski
Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells.
Molecular genetics and metabolism 2008;95(3):163-8.
2008: David F Moore; Ehud Goldin; Monique P Gelderman; Chevalia Robinson; Jessica Baer; Markus Ries; Abdel G Elkahloun; Roscoe O Brady; Raphael Schiffmann
Apoptotic abnormalities in differential gene expression in peripheral blood mononuclear cells from children with Fabry disease.
Acta paediatrica (Oslo, Norway : 1992). Supplement 2008;97(457):48-52.
2008: Surya N Gupta; Markus Ries; Gary J Murray; Jane M Quirk; Roscoe O Brady; Jeffrey R Lidicker; Raphael Schiffmann; David F Moore
Skin-impedance in Fabry Disease: a prospective, controlled, non-randomized clinical study.
BMC neurology 2008;8():41.
2007: David F Moore; Christine R Kaneski; Hasan Askari; Raphael Schiffmann
The cerebral vasculopathy of Fabry disease.
Journal of the neurological sciences 2007;257(1-2):258-63.
2007: David F Moore; Monique P Gelderman; Paulo A Ferreira; Steven R Fuhrmann; Haiqing Yi; Abdel G Elkahloun; Lisa M Lix; Roscoe O Brady; Raphael Schiffmann; Ehud Goldin
Genomic abnormalities of the murine model of Fabry disease after disease-related perturbation, a systems biology approach.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(19):8065-70.
2007: David F Moore; Markus Ries; Evelyn L Forget; Raphael Schiffmann
Enzyme replacement therapy in orphan and ultra-orphan diseases: the limitations of standard economic metrics as exemplified by Fabry-Anderson disease.
PharmacoEconomics 2007;25(3):201-8.
2007: Markus Ries; H Jeffrey Kim; Christopher K Zalewski; M A Mastroianni; David F Moore; Roscoe O Brady; James Dambrosia; Raphael Schiffmann; Carmen C Brewer
Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease.
Brain : a journal of neurology 2007;130(Pt 1):143-50.
2006: Christine R Kaneski; David F Moore; Markus Ries; GC Zirzow; Raphael Schiffmann
Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease.
Neurology 2006;67(11):2045-7.
2006: David F Moore; Monique P Gelderman; Steven R Fuhrmann; Raphael Schiffmann; Roscoe O Brady; Ehud Goldin
Fabry disease and vascular risk factors: future strategies for patient-based studies and the knockout murine model.
Acta paediatrica (Oslo, Norway : 1992). Supplement 2006;95(451):69-71.
2006: Markus Ries; David F Moore; Chevalia J Robinson; Cynthia J Tifft; Kenneth N Rosenbaum; Roscoe O Brady; Raphael Schiffmann; Donna Krasnewich
Quantitative dysmorphology assessment in Fabry disease.
Genetics in medicine : official journal of the American College of Medical Genetics 2006;8(2):96-101.
2005: Gheona Altarescu; David F Moore; Raphael Schiffmann
Effect of genetic modifiers on cerebral lesions in Fabry disease.
Neurology 2005;64(12):2148-50.
2005: Markus Ries; Surya Gupta; David F Moore; Vandana Sachdev; Jane M Quirk; Gary J Murray; Douglas R Rosing; Chevalia Robinson; Ellen Schaefer; Andreas Gal; James Dambrosia; Scott C Garman; Roscoe O Brady; Raphael Schiffmann
Pediatric Fabry disease.
Pediatrics 2005;115(3):e344-55.
2005: David F Moore; Hong Li; Neal Jeffries; Violet Wright; Ronald A Cooper; Abdel G Elkahloun; Monique P Gelderman; Enrique Zudaire; Gregg Blevins; Hua Yu; Ehud Goldin; Alison E Baird
Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation.
Circulation 2005;111(2):212-21.
2004: David F Moore; Frank Ye; Marie-Luise Brennan; Surya Gupta; Bruce A Barshop; Robert D Steiner; William J Rhead; Roscoe O Brady; Stanley L Hazen; Raphael Schiffmann
Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality: an arterial spin tagging study.
Journal of magnetic resonance imaging : JMRI 2004;20(4):674-83.
2003: David F Moore; Gheona Altarescu; W Craig Barker; Nicholas Patronas; Peter Herscovitch; Raphael Schiffmann
White matter lesions in Fabry disease occur in 'prior' selectively hypometabolic and hyperperfused brain regions.
Brain research bulletin 2003;62(3):231-40.
2003: Raphael Schiffmann; Mary Kay Floeter; James Dambrosia; Surya Gupta; David F Moore; Yehonatan Sharabi; Ramesh K Khurana; Roscoe O Brady
Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease.
Muscle & nerve 2003;28(6):703-10.
2003: David F Moore; Frank Ye; Raphael Schiffmann; John A Butman
Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease.
AJNR. American journal of neuroradiology 2003;24(6):1096-101.
2002: Gheona Altarescu; Mei Sun; David F Moore; Janine A Smith; Edythe A Wiggs; BI Solomon; Nicholas Patronas; Karen P Frei; Surya Gupta; Christine R Kaneski; O W Quarrell; Susan A Slaugenhaupt; Ehud Goldin; Raphael Schiffmann
The neurogenetics of mucolipidosis type IV.
Neurology 2002;59(3):306-13.
2002: David F Moore; Gheona Altarescu; Peter Herscovitch; Raphael Schiffmann
Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease.
BMC neurology 2002;2():4.
2002: David F Moore; Gheona Altarescu; Geoffrey S F Ling; Neal Jeffries; Karen P Frei; Thais Weibel; Gustavo Adolfo Charria-Ortiz; Raymond Ferri; Andrew Arai; Roscoe O Brady; Raphael Schiffmann
Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement.
Stroke; a journal of cerebral circulation 2002;33(2):525-31.
2002: David F Moore; Raphael Schiffmann; Aziz Ulug
Elevated CNS average diffusion constant in Fabry disease.
Acta paediatrica (Oslo, Norway : 1992). Supplement 2002;91(439):67-8.
2002: David F Moore; Gheona Altarescu; Randall Pursley; Umberto Campia; Julio A Panza; Emilios Dimitriadis; Raphael Schiffmann
Arterial wall properties and Womersley flow in Fabry disease.
BMC cardiovascular disorders 2002;2():1.
2001: Yoshiaki Itoh; Takanori Esaki; Michelle Cook; P Qasba; Kazuaki Shimoji; J Alroy; Roscoe O Brady; Louis Sokoloff; David F Moore
Local and global cerebral blood flow and glucose utilization in the alpha-galactosidase A knockout mouse model of Fabry disease.
Journal of neurochemistry 2001;79(6):1217-24.
2001: David F Moore; L T Scott; M T Gladwin; Gheona Altarescu; Christine R Kaneski; K Suzuki; M Pease-Fye; R Ferri; Roscoe O Brady; Peter Herscovitch; Raphael Schiffmann
Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy.
Circulation 2001;104(13):1506-12.
2001: David F Moore; Peter Herscovitch; Raphael Schiffmann
Selective arterial distribution of cerebral hyperperfusion in Fabry disease.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 2001;11(3):303-7.
2001: Gheona Altarescu; David F Moore; Randall Pursley; Umberto Campia; S Goldstein; M Bryant; Julio A Panza; Raphael Schiffmann
Enhanced endothelium-dependent vasodilation in Fabry disease.
Stroke; a journal of cerebral circulation 2001;32(7):1559-62.
2001: Raphael Schiffmann; Jeffrey B Kopp; Howard A Austin; Sharda G Sabnis; David F Moore; Thais Weibel; James E Balow; Roscoe O Brady
Enzyme replacement therapy in Fabry disease: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2001;285(21):2743-9.
2001: Simona Bonavita; Raphael Schiffmann; David F Moore; Karen P Frei; B Choi; N Patronas MD; Anette Virta; O Boespflüg-Tanguy; Gioacchino Tedeschi
Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations.
Neurology 2001;56(6):785-8.
2001: Roscoe O Brady; Gary J Murray; David F Moore; Raphael Schiffmann
Enzyme replacement therapy in Fabry disease.
Journal of inherited metabolic disease 2001;24 Suppl 2():18-24; discussion 11-2.
2000: Gheona Altarescu; Raphael Schiffmann; CC Parker; David F Moore; Constance Kreps; Roscoe O Brady; Norman W Barton
Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease.
Blood cells, molecules & diseases 2000;26(4):285-90.